GW Pharmaceuticals, a biopharmaceutical company with a focus on cannabinoid-based medicines, has received fast track approval from the U.S. Food and Drug Administration (FDA) for a medicine designed to treat newborns deprived of oxygen during childbirth, which can lead to brain damage and death. The FDA gave approval to an intravenous form of cannabidiol (CBD) …
Tag: GW Pharmaceuticals
FDA Gives Fast Track Approval to Cannabis Medicine for Newborns
- By Anthony Martinelli in News
August 10, 2015
Archives
Recent Posts
- World Health Organization Expert Committee Calls For Changes In Cannabis’ International Classification
- Legislation to Legalize Marijuana Passed by New Mexico Committee
- Hawaii Committee Unanimously Approves Bill to Legalize Marijuana
- Study: Marijuana Consumption Linked to Increased Sperm Count
- Washington Senate Committee Passes Bill to Allow Patients to Buy Medical Marijuana Tax Free
- Oregon Garnered Over $107 Million in Marijuana Taxes in 2018
- Weekend Unlimited Wins the “Pot” Lottery
- For Sixth Straight Year, Super Bowl Features Team from a Legal Marijuana State
Thank you for reading TheJointBlog.com!